answer text |
<p>When fully operationally in 2022, the Vaccines Manufacturing and Innovation Centre
(VMIC) will have several Good Manufacturing Process suites that will be able to accommodate
a range of production scale capabilities. For pandemic response, the VMIC will be
able to make up to 70 million doses of a vaccine within a 6-month timeframe. This
is a significant increase to the VMIC’s originally anticipated capacity.</p><p> </p><p>The
VMIC has been designed to be a flexible manufacturing facility and will be able to
manufacture a range of vaccine types, such as messenger RNA, viral vector, or protein
sub-unit.</p>
|
|